Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYBR CyberCare the new look of healthcare -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (1455)	5/2/2000 12:45:00 PM
From: sommovigo	Read Replies (2) \| Respond to of 3392

THIS LOOKS FINE------------> Greenberg clearly doesn't understand what he is writing about. That you buy into what he has to say about it reveals that you don't know what he is writing about, either. CYBR can lawfully promote and sell the EHC out of the country (a fact skirted by our Mr. Greenberg) and has done so to China (a fact skirted by our Mr. Greenberg). CYBR also can also lawfully disclose pilot programs before the 510k (FDA) is approved (a fact skirted by our Mr. Greenberg), and can also announce intended contracts that are pending upon FDA approval (as long as the clause "pending" is used, a fact skirted by our Mr. Greenberg)... which makes one think, if Mr. Greenberg was talking out of his ass, which Truthseeker has his hand IN there to begin with? I suspect that Greenberg did not research CYBR one iota past what he decided the conclusion would be after being handed biased and unfocused information by the likes of Fnord Schliedly. The article, and the author, are beyond redemption and are clearly untrustworthy... Unnamed (and un-ranked) sources at the FDA? But clearly states the names of CYBR personnel? I would call him a buffoon, but it would be to the detriment and expense of buffoons.

To: StockDung who wrote (1455)	5/2/2000 5:09:00 PM
From: Jim Gary	Read Replies (1) \| Respond to of 3392

Regarding ethics and abiding by rules: I saw the article, "Is Cyber-Care Abiding by the Rules of the FDA?", referenced in Yahoo News. When I went to the site it required a sign up for a FREE trial of their subscription service. I am sure had I signed up I could have read the article. I am just as sure that there was a standard disclaimer regarding its publication elsewhere without permission because it was copyrighted. My question... Was this article copyrighted and if so was it reprinted with the permission of The Street or not? If not then its publication here was probably a violation of copyright laws. This seems an equal if not more questionable activity than promoting the product before having FDA approval! Jim